TruAlt Bioenergy Ltd Q2 FY27 results (latest), Jul–Sep 2026 →Revenue ₹811 Cr +605.2% YoYSee revenue, profit and what management said. You are viewing Q2 FY26.
TB

TruAlt Bioenergy Ltd

Q2 FY26Agricultural Food & other Products

TruAlt Bioenergy Q2 FY26 earnings call: Revenue & Margins

Q2 FY26 earnings call: what management said on revenue, margins and capex.

Revenue
₹115Cr
−70.4% YoY
−62.2% QoQ
Net profit
−₹38Cr
Q2 FY25: −₹19 Cr
Margin
−4%
−8.5 pp YoY
−18 pp QoQ
Price₹446
Market cap₹4.0K Cr
P/E25.3

The short version

FY26 ethanol volume target revised to 36-37 crore liters (previously 41 crore liters). TruAlt Bioenergy expects a strong growth trajectory aligned with past performance trends, driven by diversified verticals: ethanol, CBG, retail fuel, and upcoming SAF segment.

From TruAlt Bioenergy Ltd's Q2 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • FY26 ethanol volume target revised to 36-37 crore liters (previously 41 crore liters).
  • H1 FY26 ethanol volume was 5.7 crore liters; expecting 31-32 crore liters in H2 FY26.
  • Q3 and Q4 FY26 expected to contribute around 26-28 crore liters of ethanol production.
  • Ethanol expected to remain primary revenue driver in next financial year, contributing ~85% of gross revenue; CBG (Compressed Biogas) to account for ~15%.
  • Multiple feedstock integration (syrup, maize, rice, damaged food grains) enables year-round ethanol production beyond sugarcane season.
  • CBG vertical expanding with 16-17 plants planned over next 9-12 months; current EBITDA margins 60-65%.
  • SAF (Sustainable Aviation Fuel) plant commercial production expects commissioning by Aug-Sep 2027; revenue from FY28.

2 more points from TruAlt Bioenergy Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what TruAlt Bioenergy Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • TruAlt Bioenergy has an MOU signed with Andhra Pradesh government for a project estimated at INR 2,250 crores.
  • Planned funding mix is approximately 30% equity and 70% debt, with potential for strategic partners and innovative financing models.
  • The project IRR is expected around 19% with a payback period of 3.5 to 4 years, assuming 85%-90% capacity utilization.
  • Expansion includes setting up 16-17 additional CBG plants within 9-12 months, boosting EBITDA margins to 60%-65%.

2 more points from TruAlt Bioenergy Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Agricultural Food & other Products

Ranked on what management guided this quarter

Guidance-ranked
1Vintage Coffee
Rev 1Mar 1
Rev 1Mar 2
3
Rev 1Mar 2
4
Rev 1Mar 3
5
Rev 2Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what TruAlt Bioenergy Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

  • TruAlt Bioenergy has a targeted ethanol supply order book of approximately 47 crore liters for the ethanol supply year Nov 2025–Oct 2026.
  • Out of this, about 34 crore liters are allocated from government OMCs, and around 5.8 crore liters from private OMCs (Jio and Nayara combined).
  • For FY25, the company supplied about 26.57 crore liters of ethanol.
  • There is a pending/disputed allocation of 14 crore liters from the last ethanol year.

2 more points from TruAlt Bioenergy Ltd's call on order book

Create a free account to keep reading this call

TruAlt Bioenergy Ltd — Quarterly revenue & net profit

Revenue Net profit Net loss
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

TruAlt Bioenergy Ltd Q2 FY26 results — key figures

TruAlt Bioenergy Ltd Q2 FY26 reported results vs Q2 FY25, ₹ crore
₹ CrQ2 FY26Q2 FY25YoYQ1 FY26QoQ
Revenue115388-70.4%304-62.2%
Operating profit (EBITDA)-517-129.4%42-111.9%
Operating margin-4%4.5%-8.5 pp14%-18 pp
Profit before tax-49-16—6-916.7%
Net profit (PAT)-38-19—5-860%
EPS (₹)-4.42-2.64—0.67-759.7%

Source: reported quarterly figures (Screener), ₹ crore.

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹811 Cr, net profit ₹35 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Agricultural Food & other Products this season

  • TBI Corn (Q2 FY26)

    Revenue from Operations for H1FY26: INR 1,367.0 Mn (45.5% YoY growth from H1FY25's INR 939.8 Mn). Key investor presentation takeaways from TBI Corn Ltd's Q2 FY2

  • GRM Overseas (Q2 FY26)

    362.4 Crores, up 14.9% YoY from Rs. Key investor presentation takeaways from GRM Overseas Ltd's Q2 FY26 investor presentation — and how it ranks against sector

  • Uttam Sugar Mills (Q2 FY26)

    561.27 Cr, up from Rs. Key investor presentation takeaways from Uttam Sugar Mills Ltd's Q2 FY26 investor presentation — and how it ranks against sector peers.

  • Regaal Resources (Q2 FY26)

    For Q2 FY26, Operating Income (revenue) was ₹3,200.2 million, up 56.5% year-on-year. Key investor presentation takeaways from Regaal Resources Ltd's Q2 FY26 inv

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

TruAlt Bioenergy Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were TruAlt Bioenergy Ltd Q2 FY26 results?

FY26 ethanol volume target revised to 36-37 crore liters (previously 41 crore liters). TruAlt Bioenergy expects a strong growth trajectory aligned with past performance trends, driven by diversified verticals: ethanol, CBG, retail fuel, and upcoming SAF segment.

What is TruAlt Bioenergy Ltd share price analysis?

TruAlt Bioenergy Ltd currently shows a neutral. The stock trades at a P/E of 25.3 with a market cap of ₹3,958 Cr. Investors should review the full earnings analysis for detailed insights.

Is TruAlt Bioenergy Ltd planning capital expenditure?

TruAlt Bioenergy has an MOU signed with Andhra Pradesh government for a project estimated at INR 2,250 crores.

Keep TruAlt Bioenergy Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.